| 23rd week of 2017 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20170156956 | NURSING BED AND CONTROL METHOD THEREOF - A nursing bed including a bed body, provided with a plurality of combined bed boards, at least one of the plurality of combined bed boards being provided with one or more pressure sensors, and a comparator, connected to the one or more pressure sensors. The comparator is configured to compare pressure data transmitted by the one or more pressure sensors with a predetermined pressure value and output a warning signal when the pressure data transmitted by the one or more pressure sensors is greater than or equal to the predetermined pressure value. A timer, is connected to the comparator, and with respect to each of the pressure sensors, configured to start timing when the warning signal is received and output an alarm signal when a preset time is reached, and an alarm device, is connected to the timer, and configured to give an alarm after the alarm signal is received. | 2017-06-08 |
| 20170156957 | COLLAPSIBLE FOOT SUPPORT - A novel foot support device includes a first sidewall adapted to engage the lateral side of a first foot, a second sidewall adapted to engage the lateral side of a second foot, and a backwall adapted to engage both the plantar region of the first foot and the plantar region of the second foot. In a particular embodiment, the first sidewall includes an inclined interior surface, the second sidewall includes an inclined interior surface, and the backwall includes an inclined interior surface. In another particular embodiment, the foot support device includes sidewalls and a backwall that can flatten and pivot relative to one another, facilitating a collapsible foot support device. | 2017-06-08 |
| 20170156958 | PILLOW - The present invention discloses a pillow for allowing a user to sleep comfortably irrespective of physical characteristics of the user. The pillow of the present invention comprises: a body formed of a cushioning material; a cervical vertebrae support part integrated with the body and provided at the middle portion of the body; a head support part integrated with the body, provided at the middle portion of the body and arranged to be separated from the cervical vertebrae support part at a fixed distance; and a spacing part arranged between the cervical vertebrae support part and the head support part and forming a space, wherein the cervical vertebrae support part includes a curved extended part extended to the spacing part, and a curved groove part provided at the inside of the lower surface of the curved extended part and engraved in a direction facing the body of the user. | 2017-06-08 |
| 20170156959 | Rotational/Translational Transfer Lift - A device positioned near a user provides support to the user in sitting and standing positions. The user can move from sitting to standing, without assistance, even if the user is relatively weakened. The device includes (1) a base and tower, and provides support to the user when in-between; (2) a personal support coupled to the tower, and operated by a user control, such as a wheel or a motor. The tower can include padding or knee support | 2017-06-08 |
| 20170156960 | Multifunctional Aircraft Aisle Wheelchair and Related Systems and Methods - The various embodiments disclosed herein relate to wheelchair systems for transporting a mobility-challenged passenger onto an aircraft and transfer that passenger into an aircraft seat. The implementations include systems with lift systems, belt systems, and/or transfer ramps. | 2017-06-08 |
| 20170156961 | MOBILE CHAMBER APPARATUSES AND RELATED METHODS - A mobile chamber apparatus includes a support structure of inflatable support members, and a chamber assembly. The inflatable support members may include transverse and upright sections. The chamber assembly may include a top wall, a bottom wall, and one or more side walls. Connectors may detachably couple the support structure and the chamber assembly. Installed, the support structure supports the chamber assembly to enclose an interior space. Inlets may deliver a supply airflow to the interior space, and outlets may deliver a return airflow from the interior space. An environmental control unit may deliver the supply airflow and receive the return airflow. At least one mechanism may be provided for introducing an allergen into the interior space. Human patients may be exposed to the allergen in the interior space, and therefore the mobile chamber apparatus may be used for clinical trials to study allergy response. | 2017-06-08 |
| 20170156962 | LUMBAR ALIGNING MOVEMENT ASSISTING DEVICE - The present invention relates to a lumbar aligning movement assisting device and, more particularly, to a lumbar aligning movement assisting device including a body formed as a cylinder and having acupressure rods capable of revolving, wherein a user can use one's own body to subject the lumbar region to acupressure and relax the muscles in order to strengthen the muscles, and can stretch the lumbar region so as to have the effect of a traction exercise of the lumbar vertebrae. | 2017-06-08 |
| 20170156963 | LEG ORTHOSIS AND ORTHOSIS - A leg orthosis including a securing device for securing the leg orthosis to the body of a orthosis user and at least one articulation device by means of which a first orthosis component, which can be fixed to an extremity of the user, is mounted such that it can pivot with respect to the securing device. The articulation device includes at least three joints, which respectively comprise at least one pivot axis, and each pivot axis intersects at a common point. | 2017-06-08 |
| 20170156964 | SPATIAL SENSING DEVICE - A spatial sensing device to improve the user's movement ability and provide assistance in the autonomous walking of visually impaired or blind people, which is also easy-to-use, ergonomic and portable, the device comprises a housing including a set of modules; attaching means bonded to the housing in order to secure the device to the user; at least one user information access means; and an ultrasound transducer positioned at the junction between one housing side and the attaching means; the device is characterized in that the ultrasound transducer is positioned on the device at a slant angle (α) with respect to the device axis (Z), such that during the use of the device, the ultrasound transducer is directed toward the user's front side in order to emit and detect signals which will be processed by the set of modules in the housing, wherein the set of modules comprises a processing module interacting with an intercommunication module, a position and/or movement sensing module, a spatial sensing module, and a power module. | 2017-06-08 |
| 20170156965 | VIRTUAL REALITY APPARATUS AND METHODS THEREFOR - Virtual reality apparatus, and various methods therefore. | 2017-06-08 |
| 20170156966 | CARPAL TUNNEL SYNDROME REHABILITATION DEVICE - A rehabilitation device for treating carpal tunnel syndrome and tennis elbow is disclosed. The rehabilitation device includes upper and lower members clamping a wrist from above and below. An upper bulge element and a lower bulge element are correspondingly positioned in the middle of the inner faces of the upper and lower members, respectively, for pressing against a gap between the ulna and radius of the wrist from above and below. The upper member has two positioning elements on the inner face to the lateral sides of the upper bulge element. A strap wraps around outer faces of the upper and lower members so as to tight the upper and lower members on the wrist from above and below. By swinging the palm up and down, the bulge elements press into the gap and provide massage and relaxation to the ligament inside. | 2017-06-08 |
| 20170156967 | WOUND CLEANSING APPARATUS WITH STRESS - An apparatus for cleansing wounds with means for stressing the wound bed and optionally tissue surrounding the wound, in which irrigant fluid from a reservoir connected to a conformable wound dressing and wound exudate from the dressing are recirculated by a devise for moving fluid through a flow path which passes through the dressing and a means for fluid cleansing and back to the dressing. The cleansing means (which may be a single-phase, e.g. micro-filtration, system or a two-phase, e.g. dialytic system) removes materials deleterious to wound healing, and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned to the wound bed. The means for stressing the wound bed and optionally tissue surrounding the wound promotes wound healing. The dressing and a method of treatment using the apparatus. | 2017-06-08 |
| 20170156968 | Arm Therapy Device - An arm therapy device for the prevention and treatment of repetitive stress injuries of the elbow, forearm, and wrist. The arm therapy device generally includes a housing adapted to be freestanding in an upright manner. The housing includes an upper opening which provides access to the interior of the housing. Rollers across the interior of the housing comprising pairs of rollers which are biased inwardly toward each other. Bias members such as resistance bands may be utilized to bias each pair of rollers toward each other. Collars may be utilized on the rollers to which the bias members are connected. By using the present invention, one may treat a limb such as an arm without having to support the housing with another hand or another person. As the limb passes through the housing, the rollers will exert pressure on the limb which aids in treating or preventing repetitive stress injuries. | 2017-06-08 |
| 20170156969 | Foot Massaging Assembly - A foot massaging assembly for massaging a foot includes a base that may be positioned on a support surface. A pair of mounts is provided and each of the mounts is coupled to the base. A massage unit is rotatably coupled between the mounts. The massage unit may have a foot rolled thereon thereby facilitating the massage unit to massage the foot. | 2017-06-08 |
| 20170156970 | FOOT STRETCHER - A foot stretcher assembly for stretching a foot includes a foot stretcher and a handle removably secured with the foot stretcher. The foot stretcher includes a sole that is flexible in response to receiving a foot. The foot stretcher assembly can also include a securing feature to maintain the foot relative to the foot stretcher. | 2017-06-08 |
| 20170156972 | Motion-Based Control for a Personal Massager - A personal massage apparatus includes a personal massager and can also include a controller for controlling the operation of the massager. The massager includes a motor or other motion-causing device and can also include an interface (e.g., a wireless interface) to the controller (where such a controller is included). The controller is a remote control that can include a motion sensor (e.g., an accelerometer) for detecting motion of the controller (e.g., changes in orientation). The massager can also have a motion sensor for detecting motion of the massager. Circuitry in the controller and/or massager converts the detected motion of the controller or massager into control signals for the controller or massager. The operation of the controller or massager (e.g., the output motor power, a vibration pattern, or another massage setting) is adjusted based on the detected motion of the controller or massager. | 2017-06-08 |
| 20170156973 | SYSTEMS AND METHODS FOR MODULATING PRESSURE WAVE THERAPY - A processor-controlled, energy-based therapy apparatus includes a device configured to provide therapeutic energy to a patient and a processor that controls the output of the device. The output of the device is based on output profiles programmed into the processor. The output profiles include a therapeutic energy output profile and a ramp-up energy profile. The therapeutic energy output profile includes a desired target energy level and a therapeutic duration for controlling the output of the device during a therapeutic period. The ramp-up energy output profile includes an initial treatment energy level and a ramp-up duration for controlling the output of the device during a ramp-up period. The energy output specified by the ramp-up energy output profile incrementally increases over the ramp-up duration as a function of the desired target energy level and the ramp-up duration. | 2017-06-08 |
| 20170156974 | DEVICE FOR DELIVERY OF RESONANT FREQUENCIES TO TREATED MUSCLES - A drumming device for delivering a repetitive percussive strike to muscles below a skin surface comprises a main housing enclosing an electric motor with a shaft having a fixed rotational speed, a drive pulley, a toothed belt encircling the drive pulley and a driven pulley with an integral cam mounted on said pulley such that the rotating shaft causes the driven pulley to rotate at a predetermined number of cycles per second, the assembly causing a repetitive, reciprocal movement of a plunger body a fixed distance and at 16.6 cycles/sec, said plunger movable in a downward direction following contact with the cam, such that the plunger reciprocates within said housing when said cam member contacts the plunger causing the plunger shaft to move laterally outward. When the massaging device is properly position in contact with the skin the moving plunger causes muscle spindles to vibrate at their resonant frequency. | 2017-06-08 |
| 20170156975 | MASSAGE APPARATUS WITH INTEGRATED ROTATING AND RECIPROCATING MASSAGE MECHANISMS - A massage apparatus with integrated rotating and reciprocating massage mechanisms is capable of providing distinct shiatsu and tapping massage effects independently and simultaneously. The massage apparatus includes at least one rotating massage node rotating about an axis to form a circular path and at least one reciprocating massage node reciprocating inside the circular path. The rotating massage node(s) may rotate on a rotating base driven by a rotating drive mechanism (e.g., a motor), and the reciprocating massage node(s) may be driven by a reciprocating drive mechanism (e.g., a solenoid) through an aperture in the rotating base. The massage apparatus may include one or more sets of integrated rotating and reciprocating massage mechanisms. The massage apparatus may be enclosed in different types of enclosures (e.g., massage chair, cushion, chair topper, drapable enclosure) configured to engage various parts of the body (e.g., neck, back, shoulders) to impart the massage effects. | 2017-06-08 |
| 20170156976 | SYSTEMS AND METHODS FOR MONITORING A SUBJECT'S EFFECTIVE USE OF A SELF-CONTAINED PORTABLE POSITIONABLE OSCILLATING MOTOR ARRAY - In some embodiments, a method may include monitoring use of a medical device. The method may include positioning a wearable harness of a medical device on a subject. The method may include selectively positioning at least some of a plurality of engines on and/or adjacent at least one treatment area. The method may include applying an oscillation force to at least one of the treatment areas using at least some of the engines. The method may include mobilizing at least some secretions in an airway within the subject substantially adjacent the treatment areas. The method may include monitoring use of the medical device by the subject using a controller associated with the medical device to determine if the medical device has been used effectively as prescribed. | 2017-06-08 |
| 20170156977 | COMPENSATION FOR DEFLECTION IN AN AUTOMATED CARDIOPULMONARY COMPRESSION DEVICE - A cardio-pulmonary compression system includes a compression device ( | 2017-06-08 |
| 20170156978 | CARDIOPULMONARY RESUSCITATION SYSTEM, CARDIOPULMONARY RESUSCITATION DEVICE, AND ARTIFICIAL RESPIRATOR - An object of the present invention is to provide a cardiopulmonary resuscitation system in which a cardiopulmonary resuscitation device is made compact and which is capable of performing blowing of breathable gas into a patient at more appropriate timing. A cardiopulmonary resuscitation system ( | 2017-06-08 |
| 20170156979 | CARDIOPULMONARY COMPRESSION DEVICE RECEIVING FLIP-UP LEGS - A cardio-pulmonary compression board includes a board ( | 2017-06-08 |
| 20170156980 | Disposable Liner for a Foot Spa with Inner and Outer Layers - A liner for containing a soaking solution in use with a foot spa features two bodies of plastic which are joined at an interface therebetween so as to form two, individual layers. An air conduit is formed between the two layers so as to provide a passageway for pressurized air, which is supplied by an air discharge apparatus, across walls of the liner and into the soaking solution. The inner layer has openings such that the air guided through the air conduit can be released into an inside volume of the liner where the soaking solution is containable. Furthermore, the outer layer is imperforate from a location thereon at which a starting end of the air conduit is disposed to a free end of the layers so as to isolate the inside volume of the liner from the soaking basin. | 2017-06-08 |
| 20170156981 | EYE WASHING NOZZLE AND EYE WASHING LIQUID CONTAINER - An eye washing nozzle includes a base portion and a tubular portion and is attached to a container body portion. The base portion is a portion to be fixed to the container body portion. The tubular portion is connected to the base portion. The tubular portion is a portion through which the eye washing liquid passes. The leading end portion of the tubular portion is provided with a discharging port that discharges the eye washing liquid that has passed through the tubular portion. | 2017-06-08 |
| 20170156982 | ACUPUNCTURE AND MOXIBUSTION TREATMENT SUPPORT TERMINAL DEVICE AND MEDICAL SUPPORT SYSTEM - To provide an acupuncture and moxibustion treatment support terminal device and a medical support system that ensures to manage data on a patient's symptoms, contents of a treatment, and the like in a clinic, to properly supply information on acupoints and the like to an acupuncturist, and to build a network among clinics, hospitals, and patients. The acupuncture and moxibustion treatment support terminal device is a terminal device 100 provided with a display input unit adapted to display information from and input information to a terminal or a server that stores two-dimensional or three-dimensional information on a human body model | 2017-06-08 |
| 20170156983 | Mixing/Administration Syringe Devices, Protective Packaging and Methods of Protecting Syringe Handlers - Medicant mixing/administration systems are provided that can include: a medicant vial; a syringe assembly comprising a barrel and a piston; a protective material supporting the syringe assembly and medicant vial; and a member within the system, the member separating the piston of the syringe assembly from the medicant vial. Systems are provided that can include: a syringe assembly comprising a barrel and a piston; having a forward end and an opposing back end; a protective material supporting the syringe assembly; and a needle housing coupled to the protective material. Medicant mixing/administration methods are also provided that can include, within a package, sufficiently clearing a restraining member from between a medicant vial and syringe plunger to pierce the medicant vial with a piercing structure coupled to the syringe plunger, the piercing providing medicant from the vial to the syringe assembly. Additional methods can include, upon opening a package containing a syringe assembly, extending a needle housing from the package. | 2017-06-08 |
| 20170156984 | NON-VENTED VIAL ACCESS SYRINGE - A syringe includes a plunger having a plunger tube with proximal and distal ends, a center tube with a center passage that extends within the plunger tube, and a balloon disposed over the center tube and sealingly fixed to at least one of the center tube and the plunger tube. The syringe also includes a barrel having a barrel tube having proximal and distal ends and an interior configured to accept a portion of the plunger, a tip fixedly coupled to the proximal end of the barrel tube, a post fixedly attached to the tip and extending within the barrel tube toward the distal end, the tip configured to partially extend into the center passage of the plunger, and a gas passage extending from a proximal end of the tip to the distal end of the post. | 2017-06-08 |
| 20170156985 | PERSONAL ELECTRONIC MEDICATION SAFE - This invention is to provide a machine to securely store, monitor and dispense prescription drugs in pill form to a specific patient as directed by a doctor. It also intends to be a safe lockbox to prevent unauthorized users and children access to the prescribed medication. This is accomplished with a programmable electronic device, which controls time and dosage quantity, biometric access pad to engage dispensing apparatus and administration of medicine to the patient, GPS tracking and pressure sensors to report theft and tampering. This machine has the potential to end pill prescription drug abuse in patients and greatly reduce the use of these prescriptions for illegal recreation. | 2017-06-08 |
| 20170156986 | Pill Bottle Labeling System - A pill bottle labeling system having a pill bottle, open top housing. The housing is used for holding a plurality of pill bottles with bottle caps. The system includes a plurality of bottle cap labels with an adhesive backing. The bottle cap labels having different drug names and vitamin supplement names printed thereon. The bottle cap labels are attached to a top of the bottle caps. The labels provide quick identification of a pill from a selected bottle. Also, the labeling system includes a time of day and night labels with an adhesive backing. The time of day and night labels are attached to a side of the pill bottles. The time of day and night labels provide for identifying a time of day or night when the pill is to be taken. | 2017-06-08 |
| 20170156987 | Systems and Methods for Tubing Delivery - Connector assembly (FIG. | 2017-06-08 |
| 20170156988 | HIGH-FLOW ENTERAL FEEDING SYRINGE ASSEMBLY - An enteral feeding connector facilitates an increased flow rate into and through the connector to accommodate feeding fluids requiring higher flow rates for delivery. The connector includes a male connector portion including an inlet, a fluid passage in fluid communication with the inlet, and at least one connector projection at the inlet. The connector projection defines a cross-sectional area of the inlet configured to facilitate delivering feeding fluid requiring higher flow rates through the connector. | 2017-06-08 |
| 20170156989 | INFANT CLOTHING INCORPORATING A TEETHING SURFACE - To ensure a teething object is always available to an infant the invention describes an article of infants clothing incorporating a teething surface | 2017-06-08 |
| 20170156990 | MILL BLANKS BASED ON A POLYMERIZED, FRACTURE-TOUGH PROSTHESIS MATERIAL - The subject matter of the invention is a three-dimensional moulded body, in particular a milling blank, made of a polymerisable prosthetic material, which is suitable for milling machining by means of CNC and/or CAD/CAM, having a fracture toughness of greater than or equal to 1.9 Mpa·m | 2017-06-08 |
| 20170156991 | BONDING METHOD, BONDING KIT, AND BONDING MATERIAL - To enable firm bonding to a member including a polyaryl ether ketone resin. A bonding method including: a bonding material applying step for applying, to the surface of a member including a polyaryl ether ketone resin, a bonding material including (A) a polymerizable monomer and (B) at least a portion of components for configuring a polymerization initiator, the content ratio of polymerizable monomers at least having two or more polymerizable functional groups in a (p2) molecule among all polymerizable monomers being 50% by mass or greater, and the content ratio of polymerizable monomers at least having one or more polymerizable functional groups and one or more functional groups capable of hydrogen bonding in a (p1h1) molecule being 5% by mass or greater; and a curing step for curing the bonding material. A bonding material and bonding kit using the bonding method. | 2017-06-08 |
| 20170156992 | DENTAL COMPOSITION - Dental composition comprising | 2017-06-08 |
| 20170156993 | DENTAL MATERIALS WITH DEBONDING-ON-DEMAND PROPERTIES - Radically polymerizable dental material, which contains at least one compound of Formula I: | 2017-06-08 |
| 20170156994 | TREATMENT COMPOSITIONS, APPARATUS AND METHODS FOR MODIFYING KERATINOUS SURFACES - A treatment composition for, among other things, treating human skin. These compositions are stable, particulate containing, printer compositions that have one or more particulate suspending agents. The suspending agents can be present in a concentration of from about 0.1% to about 5%, by weight. The particles in the particulate composition have a combined Particle Size Distribution D50 in the range of about 200 μm to about 500 μm, and preferably the compositions have a zeta potential of negative 20 or less, or greater than positive 20. The particulate suspending agent is preferably a polyacrylate composition, even more preferably sodium polyacrylate. The particles can be present in a concentration of from about 1% to about 30.0%, by weight, and preferably the particles in the particulate composition have a combined Particle Size Distribution D90 of less than about 1 μm. The particulate compositions may contain TiO | 2017-06-08 |
| 20170156995 | AEROSOL OIL FOAM COMPOSITIONS COMPRISING A TRIGLYCERIDE-BASED OIL AND SURFACTANT - An aerosol oil foam composition having at least one triglyceride-based oil and at least one polyglyceryl fatty acid ester surfactant. The polyglyceryl fatty acid ester surfactant includes an alkyl group having at least 10 carbon atoms and having a hydrophile-lipophile balance of between about 8 and about 13. The aerosol oil foam composition is a stable foam that is water rinsable. An aerosol oil-containing foamable composition and a process for cleansing skin, scalp or hair are also disclosed. | 2017-06-08 |
| 20170156996 | MULTI-TONAL ONE STEP DYEING WITH FOAM-TYPE PRE-TREATMENT SOLUTION - A method for the oxidative dyeing of keratinic fibers includes the following steps: applying a cosmetic agent (M1) to the keratinic fibers,
| 2017-06-08 |
| 20170156997 | Water-Gel Emulsion Compositions and Methods - A water-based composition containing oil soluble components may include an anhydrous concentrate including hydroxypropylcocoate PEG-8 dimethicone and a hydration component, which may be stored in separate vessels prior to mixing. The anhydrous concentrate may be combined with the hydration component to create a consumer product such as a topical cream. The anhydrous concentrate may include a preparation that includes a liquid dispersion polymer, an inverting surfactant and a binding agent, and also may include lipid-soluble vitamins, antioxidants and the like. The hydration component may include water and a preservative system, and also may include water-soluble vitamins, antioxidants and the like. Two forms (i.e. lipid-soluble and water-soluble) of a given ingredient (such as vitamin C) may be provided in the concentrate and the hydration component, respectively. A third vessel may be used for mixing the concentrate with the hydrator and/or dispensing the concentrate, the hydrator and/or the consumer product. | 2017-06-08 |
| 20170156998 | COMPOSITION IN THE FORM OF NANO- OR MICRO-EMULSION - The present invention relates to a composition in the form of a nano- or micro-emulsion, comprising: (a) at least one oil; (b) at least one nonionic surfactant with an HLB value of from 8.0 to 14.0, preferably from 9.0 to 13.5, and more preferably from 10.0 to 13.0; (c) at least one ceramide compound; (d) at least one anionic surfactant; and (e) water. The composition can be used as a cosmetic composition and provides an excellent feeling during use and can be transparent or slightly translucent, and is stable over time, even at an elevated temperature. | 2017-06-08 |
| 20170156999 | PERSONAL CARE COMPOSITION IN A DISSOLVABLE CONTAINER - The present disclosure describes a cleansing device. The cleansing device includes a container that is dissolvable in water. The cleansing device also includes a personal care composition. The personal care composition is disposed within the container. When the container dissolves, the personal care composition is to be deposited on a surface. | 2017-06-08 |
| 20170157000 | COSMETIC PRODUCT WITH LIPOSOMAL GROWTH FACTORS - Cosmetic product with liposomated growth factors with properties for repairing and rejuvenating the skin which include in the composition thereof high purity liposomated plant growth factors, liposomated antioxidants, liposomated anti-wrinkle peptides and stem cells in addition to other components for cosmetic use. | 2017-06-08 |
| 20170157001 | Compositions Comprising Strontium and Uses Thereof in the Treatment or Prevention of Gingivitis, Periodontitis, Periodontitis as a Manifestation of Systemic Diseases, and Necrotizing Periodontal Diseases - The present invention relates to the use of a pharmaceutical composition comprising at least one strontium salts for the preparation of a medicament for treatment and prevention of gingivitis, periodontitis (aggressive and chronic), periodontitis as a manifestation of systemic diseases and/or necrotizing periodontal diseases. The composition preferably comprises strontium carbonate, strontium chlorides and/or strontium renalate. Further included may be a vitamin D compound, preferably vitamin D | 2017-06-08 |
| 20170157002 | MULTI-TONAL ONE STEP DYEING WITH THICKENED PRE-TREATMENT SOLUTION - The invention relates to a method for dyeing keratin fibres, in particular human hair, in which alter applying and allowing a thickened pre-treatment agent in the form of a lightening or bleaching agent (M1), comprising at least one oxidation agent, to react, a dye (M2) is applied directly and is allowed to react without rinsing. By carrying out said method, hair can be coloured in a dyeing step and simultaneously multi-tonal dyeing with highlights is achieved. | 2017-06-08 |
| 20170157003 | ORAL CARE FORMULATION SYSTEM PROVIDING AMORPHOUS CALCIUM PHOSPHATE - Disclosed is a system for providing an oral care active formulation that delivers amorphous calcium phosphate (ACP) to the teeth of a subject. The system comprises a component that provides calcium ions and a component that provides phosphate ions. The invention allows to obtain increased ACP concentrations as a result of the inclusion, in either or both of the components, of one or more basic amino acids. The invention also allows providing ACP via the administration of a two-component solvent-based varnish. | 2017-06-08 |
| 20170157004 | COSMETIC COMPOSITION - The present invention relates to an anhydrous colored cosmetic powder comprising at least one natural or synthetic silicate and at least one dye. During its preparation, such a powder may have contacted an aqueous phase which has subsequently been dried and is not present in its final state. The present invention also relates to a cosmetic composition comprising an aqueous phase and a non-aqueous phase comprising at least one colored powder portion, where the colored powder portion comprises at least one natural or synthetic silicate and at least one dye. | 2017-06-08 |
| 20170157005 | Novel Anti-Wrinkle and Anti-Aging Nano Formulations and Method of Preparation using Novel Nano Co-Delivery System - The invention relates to new anti-wrinkle and anti-aging nanoformulations, composed of non-toxic mesoporous silica nanoparticles, natural plant extracts (as the case may be: pomegranate oil, fennel oil, rosemary oil, chamomile oil, jojoba oil, rosehip oil), biological active agents (acetyl hexapeptide-8, aspartic acid), vitamins and others. Additionally, the present invention relates a new method for preparing the nanoformulations by co-encapsulating its active agents within a multilayer nanocarrier, thereby, enhancing their delivery through the skin barrier and their controlled accumulation at the desired site. | 2017-06-08 |
| 20170157006 | Compositions for the Treatment of Sweating and Methods for Making Same - The invention describes novel compositions and methods utilized for treating disorders and/or conditions associated with the epidermal and/or dermal level of the skin. Such disorders include hyperhidrosis, bromhidrosis, and chromhidrosis, One representative composition of the invention comprises; water, alcohol, aluminum sesquichlorohydrate, hydroxypropyl methyl cellulose, polysorbate 20, isopropyl myristate, eucalyptus oil, silicone oil, alkyl benzoate, glycerine, talc, a hydrophillic silica, a hydrophobic silica, phenoxyethanol and ethylhexyl glycerine. | 2017-06-08 |
| 20170157007 | Plasmonic Enhancement of Absorption in Sunscreen Applications - Zinc oxide compositions as well as techniques for plasmonic enhancement of absorption in sunscreen applications are provided herein. A method includes selecting one or more metal particles to be used in conjunction with one or more zinc oxide particles in a sunscreen composition, wherein said selecting is based on the plasmon resonance frequency associated with each of the metal particles; and embedding the one or more selected metal particles into each of the one or more zinc oxide particles. | 2017-06-08 |
| 20170157008 | COMPOSITION FOR HAIR FRIZZ REDUCTION - The present invention is directed a shampoo composition for hair frizz reduction comprising from about 0.1% to about 20% of a moisture control material or mixture of moisture control materials wherein the moisture control material is selected from one or more of the following: | 2017-06-08 |
| 20170157009 | COMPOSITION FOR HAIR FRIZZ REDUCTION - The present invention is directed to a shampoo composition for hair frizz reduction comprising from about 0.1% to about 20% of a moisture control material or mixture of moisture control materials wherein the moisture control material is selected from one or more of the following: | 2017-06-08 |
| 20170157010 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS ASSOCIATED WITH DAMAGE INDUCED BY FREE RADICALS - The present invention relates to treatment of various disorders, diseases or conditions associated with or mediated by oxidative stress arising from an imbalance between the production of and the ability to neutralize reactive free radicals. The present invention is directed to methods and compositions capable of scavenging reactive free radicals for therapeutically or prophylactically treating disorders associated with free radical-induced damage, said compositions comprising an amount of 2-(3-chlorophenylamino) phenylacetic acid (23CPPA) or a pharmaceutically acceptable salt thereof that interacts with free radicals generated by cellular metabolism or ultraviolet radiation. In some embodiments, the composition comprises pharmaceutically or cosmetically acceptable adjuncts. The present invention further provides one or more kits that are useful for delaying, treating or preventing the consequences of aging and free radical damage on the condition or appearance of the skin. | 2017-06-08 |
| 20170157011 | HAIR CARE REGIMEN USING COMPOSITIONS COMPRISING MOISTURE CONTROL MATERIALS - A method is disclosed for reducing hair frizz by treating hair with a regimen comprising two or more hair care compositions wherein at least two of such compositions comprise Moisture Control Materials. Two or more of the compositions used in the method comprise from about 0.1% to about 20% of a moisture control material or mixture of moisture control materials wherein the moisture control material is selected from the group consisting of Class I and Class II. | 2017-06-08 |
| 20170157012 | A Use of Isosorbide Monooleate - The present invention relates to the use of a cosmetic composition comprising isosorbide monooleate for depositing isosorbide monooleate on human skin or hair. Furthermore it relates to a process for depositing isosorbide monooleate on human skin or hair, wherein this process comprises contacting human skin or hair with a cosmetic composition comprising isosorbide monooleate and rinsing off the cosmetic composition comprising isosorbide monooleate with water, so that, after rinsing off the cosmetic composition, isosorbide monooleate is left deposited on the human skin or hair. | 2017-06-08 |
| 20170157013 | Metal Amino Acid Complexes for Bacterial Aggregation - Disclosed herein are methods of promoting the aggregation and/or immune clearance of oral bacteria using oral care compositions comprising metal-amino acid complexes. | 2017-06-08 |
| 20170157014 | PEPTIDES, COMPOSITIONS COMPRISING THEM AND USES IN PARTICULAR COSMETIC USES - The peptides have the general following formula: X-Pro*-Pro*-Xaa-Y in which: —Xaa is selected from Leucine (Leu, L), Arginine (Arg, R), Lysine (Lys, K), Alanine (Ala, A), Serine (Ser, S), and Aspartic acid (Asp, D); —At the N terminal end of the peptide, X is selected from H, —CO—R1 and —SO | 2017-06-08 |
| 20170157015 | STEM CELL STIMULATING COMPOSITIONS AND METHODS - The inventive subject is directed towards ready-to-use topical cosmetic formulations that include at least one defensin present in sub-antimicrobially effective concentrations. Surprisingly, even at such low concentrations, defensins recruit LGR6+ stem cells from hair follicles to the interfollicular space. Including defensins in the inventive topical cosmetic formulations may reduce one or more of wrinkle depth, wrinkle length, wrinkle width, pore size, irregularity in texture of a skin surface, oiliness, brown spots, and red spots in non-injured skin, thus reducing apparent age. | 2017-06-08 |
| 20170157016 | COSMETIC COMPOSITION COMPRISING A MUCONOPEPTIDE - A cosmetic composition containing as an active substance a cosmetically effective amount of at least one mu-conotoxin peptide is provided. In particular, a composition wherein the mu-conotoxin peptide is Arginine, lysine polypeptide (INCI name: pyroglutamyl s-mu-conotoxin CnIIIc amide acetate), CAS Number: 937286-43-6 (renumbered 936616-33-0), Molecular formula C | 2017-06-08 |
| 20170157017 | ANTIPERSPIRANT COSMETIC WITH DESIGN PROTEINS, EXEMPT OF ALUMINUM AND/OR ZIRCONIUM HALIDES AND/OR HYDROXY HALIDES - The invention relates to an antiperspirant cosmetic including at least one specific design protein and which is exempt of aluminum and/or zirconium halides and/or hydroxy halides. The invention further relates to the use of a specific protein and to a non-therapeutic method for reducing body perspiration. Adding or using said at least one specific protein ensures that the sweat gland(s) is/are effectively influenced, thus resulting in a significant reduction in axillary hyperhidrosis even in the absence of antiperspirant aluminum salts. | 2017-06-08 |
| 20170157018 | GROWTH FACTOR CONCENTRATE AND THE USE THEREOF - Provided herein are growth factor concentrates, the method of preparing the growth factor concentrates, cosmetic compositions and methods for cosmetic treatment. The growth factor concentrates include decapsulated growth factors derived from platelet rich plasma. | 2017-06-08 |
| 20170157019 | LUPIN PEPTIDE EXTRACTS AND SKIN FIRMNESS - The present invention relates to the use of a lupin peptide extract to prevent loss of skin firmness or to increase the firmness of skin. Advantageously, the lupin peptide extract can prevent the appearance of cellulite and/or reduce skin cellulite. | 2017-06-08 |
| 20170157020 | METHOD OF TREATMENT OF WRINKLES USING TOPICAL CHEMODENERVATING AGENTS - Methods for reducing the appearance of wrinkles in a subject are provided herein. The methods of the present invention comprise identifying a wrinkle distribution on a subject and applying a topical composition comprising at least one chemodenervating agent onto and along the wrinkle distribution. The methods disclosed herein provide alternative methods for delivery of chemodenervating agents to the skin for the treatment of wrinkles. | 2017-06-08 |
| 20170157021 | Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent - A sunscreen composition comprised of one or more sunscreen active agents encapsulated in a cellulose derived capsule wherein the composition can contain one or more additional agents. A sunscreen composition can be mixed with a body wash, an after shower body lotion, a shampoo, a conditioner, a soap, a gel, a hand sanitizer, a cream, a spray, a mouse, a lotion, an ointment, a make-up product, a lip balm, a hair spray product, an arachnid/insect repellent or a medicinal product. | 2017-06-08 |
| 20170157022 | PHOTOCURABLE COMPOSITION FOR NAIL OR ARTIFICIAL NAIL - The present invention relates to a photocurable composition for coating a nail or an artificial nail, including:
| 2017-06-08 |
| 20170157023 | MULTI-TONAL ONE STEP DYEING WITH THICKENING PRE-TREATMENT SOLUTION - A method for dyeing keratin fibers, in particular human hair, in which, after a thickened pretreatment agent (M1) including at least one oxidation dye precursor has been applied and left to act, directly thereafter and without rinsing a coloring agent (M2) is applied and left to act. By virtue of this method, in one dyeing step the hair can be colored and at the same time a multi-tonal dyeing with lighter (“highlights”) or darker (“lowlights”) sections (strands) can be produced. | 2017-06-08 |
| 20170157024 | MULTI-TONAL ONE STEP DYEING WITH THICKENED PRE-TREATMENT SOLUTION - A method for dyeing keratinous fibers, in particular, human hair, in which, after a thickened pre-treatment agent (M1) containing no oxidation dye precursors has been applied and allowed to react, a coloring agent (M2) is applied and allowed to react immediately thereafter and without rinsing. By carrying out said method, hair can be colored in a dyeing step and simultaneously multi-tonal dyeing with highlights or lowlights can be achieved. | 2017-06-08 |
| 20170157025 | TEXTILE FRIENDLY ANTIPERSPIRANT COMPOSITIONS - The subject of the present invention is an antiperspirant composition for personal body care with an improved residue behavior, which includes a mixture of at least one volatile silicone oil, PPG-14 butyl ether, and at least one other oil, selected from 2-phenoxyethyl octanoate and PPG-3 myristyl ether. | 2017-06-08 |
| 20170157026 | USE OF HYDROPHILIC-RICH ALKYLMETHYLSILOXANE-DIMETHYLSILOXANE-POLYOXYALKYLENE COPOLYMERS AS EMULSIFIERS FOR THE PREPARATION OF COSMETIC O/W EMULSIONS OF IMPROVED AESTHETIC PROPERTIES AND MILDNESS - This invention relates to the use of hydrophilic-rich, rake-type alkylmethylsiloxane-dimethylsiloxane-polyoxyalkylene copolymers. | 2017-06-08 |
| 20170157027 | COMPOSITION FOR HAIR PACK AND A HAIR PACK COMPRISING THE SAME - The composition according to one embodiment of the present invention includes red pepper extract; and at least one extract selected from the group consisting of cabbage extract, broccoli extract, radish extract, and cauliflower extract, and can give thermal sensation, treat damaged hair, and improve hair condition. Furthermore, it is possible to care hair easily in house by using the hair pack to which the composition is applied. | 2017-06-08 |
| 20170157028 | TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS - Disclosed are methods of treating skin with topical skin compositions comprising at least one plant extract. | 2017-06-08 |
| 20170157029 | METHOD OF REGULATING A CONDITION OF MAMMALIAN KERATINOUS TISSUE - A method of regulating mammalian keratinous tissue that includes applying a safe and effective amount of achachariu to a target portion of keratinous tissue. The achachariu can be in the form of a bioactive ingredient that exhibits anti-inflammatory, anti-oxidant, anti-aging, and/or anti-protein loss properties, and which is free or substantially free of benzophenones and/or protein. The achachariu ingredient may be a serum fraction and/or an extract, and may be incorporated into a personal care composition formulated for topical use on skin and/or hair. | 2017-06-08 |
| 20170157030 | PERSONAL CARE COMPOSITION AND METHOD OF MAKING THE SAME - Personal care compositions that include bioactive ingredients derived from achachariu and methods of making the same. The bioactive compositions (ingredients) of the present invention may be free of or substantially free of benzophenones and/or protein, and may exhibit anti-inflammatory, anti-oxidant, anti-aging, and/or anti-protein loss properties. The achachariu ingredient may be in the form of a serum fraction and/or an extract. The personal care compositions are formulated for topical use on skin and/or hair. | 2017-06-08 |
| 20170157031 | METHOD OF REGULATING A SKIN CONDITION - A method of regulating a skin conditions that includes applying a safe and effective amount of achachariu to a target portion of skin in need of treatment or where treatment is desired. The achachariu can be in the form of a bioactive ingredient that exhibits anti-inflammatory, anti-oxidant, and/or anti-aging properties, and which is free or substantially free of benzophenones and/or protein. The achachariu ingredient may be a serum fraction and/or an extract, and may be incorporated into a skin care composition formulated for topical use on skin. | 2017-06-08 |
| 20170157032 | SKIN CARE COMPOSITION AND METHOD OF MAKING THE SAME - Topical skin care compositions that include bioactive ingredients derived from achachariu and methods of making the same. The bioactive compositions (ingredients) of the present invention may be free of or substantially free of benzophenones and/or protein, and may exhibit anti-inflammatory, anti-oxidant, and/or anti-aging properties. The achachariu ingredient may be in the form of a serum fraction and/or an extract. | 2017-06-08 |
| 20170157033 | TREATMENT OF KERATINIZED TISSUES - Described are methods for treating a keratinized tissue condition in a subject in need thereof. The method may include providing the subject including the keratinized tissue condition. The method may include conducting one or more treatment cycles on the keratinized tissue. Each treatment cycle may include contacting the keratinized tissue with an acid-activated gas-generating composition. Each treatment cycle may include contacting the keratinized tissue with an acid composition. Each treatment cycle may include allowing the acid composition and the acid-activated gas-generating composition to react effective to generate a gas at the keratinized tissue. The one or more treatment cycles may be effective to at least partly ameliorate the keratinized tissue condition in the subject. | 2017-06-08 |
| 20170157034 | PROBIOTIC STICK FORMULATION FOR SKIN MAINTENANCE AND METHODS OF USE - The invention relates to an anhydrous mixture of biologically active probiotic bacteria for topical administration and methods of making thereof. The mixture of the invention is used for hydrating the skin, reducing and preventing fine lines and wrinkles, treating acne and decreasing skin inflammation. | 2017-06-08 |
| 20170157035 | INTRAVASCULAR DELIVERY OF NANOPARTICLE COMPOSITIONS AND USES THEREOF - The present invention provides methods of delivering a composition comprising nanoparticles that comprise a macrolide and an albumin by directly injecting the nanoparticle composition into the blood vessel wall or the tissue surrounding the blood vessel wall. The methods can be used for inhibiting negative remodeling or vascular fibrosis in the blood vessel and are useful for treating various diseases. | 2017-06-08 |
| 20170157036 | MICRONEEDLE-BASED TRANSDERMAL DELIVERY SYSTEM AND METHOD OF MAKING SAME - A transdermal delivery system of microneedles containing a bioactive material, comprising at least one layer of a support material; at least one biodegradable needle associated with the support material, each needle comprising at least one biodegradable polymer and at least one sugar, wherein each biodegradable needle is hollow and is adapted to retain a bioactive material. | 2017-06-08 |
| 20170157037 | OPHTHALMIC COMPOSITIONS COMPRISING POLYETHER SUBSTITUTED POLYMERS - The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300. | 2017-06-08 |
| 20170157038 | OPHTHALMIC DRUG DELIVERY METHOD - A method to provide a therapeutic agent to an eye of a patient. | 2017-06-08 |
| 20170157039 | DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE - Oral dosage forms of osteoclast inhibitors, such as zoledronic acid in an acid or a salt form, can be used to treat or alleviate pain or related conditions. | 2017-06-08 |
| 20170157040 | Manufacturing of Semi-Plastic Pharmaceutical Dosage Units - A process for the manufacture of semi-plastic pharmaceutical unit doses using a rotary moulding machine and semi-plastic pharmaceutical dosage units obtained by this process. | 2017-06-08 |
| 20170157041 | CANNABIS TABLET OR CAPSULE - An orally dissolvable cannabis tablet includes one or more active cannabis-based chemical constituents and one or more inactive constituents. The active cannabis-based chemical constituents includes at least one of cannabinoids or terpenoids. | 2017-06-08 |
| 20170157042 | GUMMY COMPOSITIONS FOR NUTRITIONAL SUPPLEMENTATION - A method for treating a prenatal, pregnant or breastfeeding patient for a disease, condition or disorder that is associated with a nutritional deficiency in the patient comprising administering at least one gummy composition to a patient. The gummy composition comprises an effective amount of vitamin A, vitamin B | 2017-06-08 |
| 20170157043 | DEVICES AND METHODS FOR PREPARING GASTRORETENTIVE DOSAGE FORMS - The present disclosure provides a device for self-preparation of a gastroretentive dosage form being capable of transitioning between a collapsed configuration and an expanded configuration, the device comprising an assembly unit including: a compartment configured for accommodating the gastroretentive dosage form in the expanded configuration; and a mechanical system configured for, upon operation of an actuation mechanism: (a) transitioning said gastroretentive dosage form into the collapsed configuration; and (b) locking said collapsed gastroretentive dosage form into the collapsed configuration; wherein the device is configured for being portable. | 2017-06-08 |
| 20170157044 | DRY POWDER MIXING PROCESS - The present invention relates to a simple, robust and effective process for preparing a dry powder inhalation formulation containing at least one drug, preferably a highly active drug, more preferably Tiotropium bromide or Tiotropium bromide monohydrate, and a lactose carrier. The process is characterized in that a three-layered composition containing a drug layer in between layers of the lactose carrier is mixed and the obtained preblend is mixed with additional lactose carrier. The process combines a simple manufacturing procedure with an excellent content uniformity obtained over a wide range of mixing parameters. | 2017-06-08 |
| 20170157045 | APPARATUS AND METHOD FOR GENERATING HYDROGEN-CONTAINING LIQUID - An object is to provide an apparatus and method for generating a hydrogen-containing liquid that are capable of generating a hydrogen-containing liquid of which the hydrogen concentration after 10 minutes exceeds 6 ppm and the hydrogen concentration after 24 hours exceeds 10 ppm. The apparatus comprises a hydrogen generating agent ( | 2017-06-08 |
| 20170157046 | GENERATION OF THERAPEUTIC MICROFOAM - Improved therapeutic sclerosing microfoams and methods and devices for making them are provided that have advantage in producing a consistent profile injectable foam with minimal input by the physician yet using high volume percentages of blood dispersible gases, thus avoiding use of potentially hazardous amounts of nitrogen. | 2017-06-08 |
| 20170157047 | DEVICES AND METHODS FOR INJECTABLE VASCULAR SCLEROFOAMS USING A CARRIER MATRIX AND USES THEREOF - The invention relates in particular to an injectable sclerosant drug foam comprising: (i) a matrix; (ii) at least one fluid; (iii) at least one sclerosant drug; (iv) a medical gas or medical gas mixture acceptable for intravenous use, (v) wherein said matrix has physical properties, which are comparable to denatured blood, wherein the denatured blood is obtainable from a fresh human venous whole blood sample of 1 ml volume, which is heated in a cylindrical polyethylene container with 3 mm inner diameter and 3.4 mm outer diameter for about 0.5 min. to about 10 min. at a temperature of about between 70° C. and 100° C. and/or (vii) said level of denaturation is defined by the change of red-colored hemoglobin to brown as an indicator, wherein Fe | 2017-06-08 |
| 20170157048 | MULTIVALENT DELIVERY OF IMMUNE MODULATORS BY LIPOSOMAL SPHERICAL NUCLEIC ACIDS FOR PROPHYLACTIC OR THERAPEUTIC APPLICATIONS - Liposomal spherical nucleic acids that function as multivalent immune modulators are provided according to the invention. The liposomal spherical nucleic acids of the invention are useful prophylactic and therapeutic applications as well as research and diagnostic indications. | 2017-06-08 |
| 20170157049 | TASTE-MASKED ORAL PHARMACEUTICAL COMPOSITION - The invention provides coated particles with a taste-masked drug substance. The particles comprise a core with the agglomerated active ingredient and a coating comprising a triglyceride and a surfactant. The particles exhibit rapid drug release and a stable release profile. Moreover, the invention provides a hot-melt coating method for manufacturing such particles, and pharmaceutical compositions comprising the particles. The method allows the coating of core particles at moderate temperatures, thereby preventing the degradation of the thermolabile active ingredient. | 2017-06-08 |
| 20170157050 | PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL - The present invention is a technical filed of pharmaceutical preparation agent, and more particular to a pharmaceutical composition containing docetaxe. The pharmaceutical composition containing docetaxe includes docetaxel and a polyethylene glycol methyl ether-polylactide block copolymer with amino acid end groups. The advantage of the present invention is subjected to a tri-block copolymer with low toxicity as the drug carrier. In addition to the pharmaceutical active ingredients and carrier, there is no other additive in pharmaceutical composition containing docetaxe. Thus, the prescription is simpler and the security is higher. In pharmaceutical component containing docetaxel, docetaxel content is more than 20%, such that the preparation process of pharmaceutical component containing docetaxel is simple, and easy for the industrial applications. | 2017-06-08 |
| 20170157051 | SOLUBILITY ENHANCEMENT FOR HYDROPHOBIC DRUGS - The present invention relates to improved pharmaceutical compositions of pharmaceutically active agents, having high bioavailability and to a method for preparing such compositions. | 2017-06-08 |
| 20170157052 | IMMEDIATE RELEASE DOSAGE FORMS THAT DETER ABUSE BY ORAL INGESTION OF MULTIPLE DOSAGE UNITS - Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses. | 2017-06-08 |
| 20170157053 | ORODISPERSIBLE TABLETS - This invention relates to a an orally disintegrating tablet obtainable by direct compression of a dry powdered mixture, said mixture comprising up to 15% by weight of calcium silicate, at least 50% of a diluent, a disintegrant agent and an active ingredient. It also relates to a process for preparing the tablets by homogeneous blending the specific excipients in powder form and subsequent direct compression of the mixture. Said tablets disintegrate quickly in the cavity of the mouth, in particular in less than 15 seconds. | 2017-06-08 |
| 20170157054 | Novel Formulations of Fat-Soluble Active Ingredients with High Bioavailability - The present invention relates to formulations of a pharmacological effective fat-soluble active ingredient with a high bioavailability of said fat-soluble active ingredient as well as to their manufacture and use as dietary supplement, food, feed, personal care product and/or pharmaceutical. Such formulations are those which when dissolved, dispersed or diluted in/with water have an extinction E 1/1 at a wavelength in the range of from 200 to 800 nm, preferably in the range of from 250 to 600 nm, more preferably in the range of from 250 to 500 nm, more preferably in the range of from 370 to 485 nm, of ≧380, preferably of ≧600, most preferably ≧900. In preferred embodiments of the formulations of the present invention such formulations show an extrusion loss of fat-soluble active ingredient of ≦30% when pressed to tablets. | 2017-06-08 |
| 20170157056 | ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF - Improved oral dosage forms of methyl hydrogen fumarate and prodrugs thereof are disclosed. Methods of treating diseases such as multiple sclerosis and psoriasis using such dosage forms are also disclose. | 2017-06-08 |
| 20170157057 | GRAFT MATERIAL AND METHOD FOR PREPARING SAME - The present invention provides a method for preparing a graft material containing organ or tissue cells, the cells including cells having inhibited PHLDA3 expression. | 2017-06-08 |
